Conclusions
This study supports the potential usefulness of elective versus provisional IABP to prevent intraprocedural major adverse cardiac and cerebral events in high-risk PCI. (Am Heart J 2003;145:700-7.)
The most common indications for intra-aortic balloon pump (IABP) for the interventionalist are 1) cardiogenic shock or left ventricular failure complicating acute myocardial infarction and 2) "rescue" of patients who have hemodynamic collapse in the catheterization laboratory during coronary angiography and/or failed percutaneous coronary interventions (PCI), as a bridge to bypass surgery. 1 The usefulness of elective IABP support in patients at high risk for complications during PCI is still controversial. [2] [3] [4] [5] [6] [7] High-risk groups have traditionally included patients with multiple-vessel and/or left main disease, age Ն70 years, prior coronary bypass surgery, and poor left ventricular function. 4 Elective IABP may provide circulatory support during PCI in patients at high risk of procedure-related morbidity and mortality, such as those with severe impairment of left ventricular systolic function. 2, 3 These patients represent an unusual challenge for the interventionalist, especially when the vessel to be treated provides blood to the remaining viable myocardium. The approach to these patients has to be tailored within a framework of high risk in which even transient ischemia may produce disastrous hemodynamic compromise. The need to get the artery open and stented quickly needs to be balanced by having an optimal result so that the longterm benefit can be realized. The risk of undertreatment must be balanced against the potential complications of prolonged ischemia during the more complex PCI approach (eg, directional and rotational atherectomy). In the current study, we sought to evaluate the role of elective IABP support during PCI in patients with left ventricular ejection fraction (EF) Յ30%.
Methods

Study population
From February 1998 to December 2000, 2500 elective PCIs were performed in our institution. This report represents a consecutive series of the 133 patients (5.3% of the total) with EF Յ30% (as assessed by cineangiography and/or echocardiography) treated with elective single-vessel PCI in our institution in this period of time. No patient with acute myocardial infarction occurring within 48 hours was included in the study. All patients signed informed consent. The decision to treat these patients with a percutaneous approach was taken on the basis of the following elements: 1) technical suitability for percutaneous revascularization with the knowledge that this approach would not have jeopardized any future surgical option, 2) patient's and/or referring physician's preference, 3) contraindications to surgical treatment.
Criteria for elective IABP support
IABP was prophylactically placed at the beginning of an elective PCI in 61 patients (group A). In the remaining 72 patients (group B), PCI was performed without elective IABP. The decision criteria to electively use an IABP was left to operator discretion, but according to the practice of our catheterization laboratories. The most common conditions for IABP were EF Յ30% (in all cases) and at least one of the following: 1) jeopardy score Ն8, 2) ongoing ischemia (that is, angina pectoris at rest as well as with minimal effort), 3) significant narrowing in a vessel giving collaterals to a total occlusion of a second vessel with blood supply to at least 40% of the left ventricular myocardium, and 4) left main equivalent (defined as critical narrowing of the proximal left anterior descending and circumflex arteries).
Presence of peripheral vascular disease (PVD) was not a contraindication to elective IABP because of 1) the use of an 8F introducer and 2) the IABP was removed at the end of procedure. These 2 elements made our criteria for IABP insertion in the context of PVD more liberal. The only relative contraindications were the absence of femoral artery pulses and/or severe pain in one or both legs on walking a short distance or in the presence of signs of leg ischemia.
Procedural characteristics and outcome
All patients assumed antiplatelet therapy (aspirin 325 mg/d and ticlopidine 250 mg twice daily) before the procedure. A low dose (70 UI/kg) of unfractionated heparin was intravenously administered at the beginning of the procedure. Abciximab was used at the operator's discretion. PCI was performed in any given patient according to operator preference-this including plain balloon angioplasty, stent implantation, and debulking techniques (rotational and directional atherectomy). In group A, an 8F IABP (Profile, Datascope System, Datascope Corporation, Fairfield, NJ) was placed percutaneously from the left femoral artery and balloon counterpulsation was initiated before starting the angioplasty procedure. Each IABP was placed through a sheath and provided one-to-one counterpulsation before coronary intervention. Depending on procedural outcome and hemodynamic stability, the IABP was either removed later the same day or was continued overnight. In all cases, the IABP and vascular sheath were removed when the activated clotting time was Ͻ200 seconds.
Definitions
Procedural-related hypotension for group A was defined as augmented diastolic pressure Ͻ90 mm Hg lasting Ͼ10 minutes; for group B, systolic pressure Ͻ90 mm Hg lasting Ͼ10 minutes. Q-wave myocardial infarction was defined as new pathologic Q waves according to the Minnesota code 8 or an increase in serum total creatine kinase (CK) Ն2 times above normal values with positive CK-MB. Non-Q-wave myocardial infarction was defined as chest pain or ST-segment or T-wave abnormalities transient or sustained associated with an increase of total CK Ն2 times above normal values with positive CK-MB without any new pathological Q wave. Slow flow was defined as the occurrence of slow or absent distal flow (Thrombolysis In Myocardial Infarction [TIMI] trial flow grade Յ2) without obvious dissection, thrombus or spasm. Angiographic success was defined as a residual stenosis Ͻ20% by visual estimate after stent implantation and Ͻ35% after balloon angioplasty; procedural success was an angiographic success without procedural-related complications. All the clinical and angiographic events were assessed and defined by the individual operators and discussed during quality assurance meetings.
Major adverse cardiac and cerebral events (MACCEs) (death, Q-wave and non-Q-wave myocardial infarction, coronary bypass surgery, stroke) and catheterization laboratory events were assessed. A catheterization laboratory event was defined as any of the 3 following events occurring after starting the intervention: 1) ventricular fibrillation or tachycardia requiring electrical cardioversion, 2) cardiopulmonary arrest requiring either external cardiac compression or intubation with assisted ventilatory support, or 3) prolonged (Ͼ10 min) hypotension with systolic blood pressure Ͻ85 mm Hg requiring intravenous pressor agents and urgent treatment with IABP (in group B). Urgent IABP support was considered in all cases of group B in which severe hemodynamic instability was unresponsive to conventional pharmacological approach (ie, fluid replacement and vasopressors).
Angiographic analysis
Patients received intracoronary isosorbide dinitrate (0.1-0.3 mg) before initial and final angiograms to achieve maximal vasodilatation. Angiographic measurements were performed with an automated computer-based system by experienced angiographers (QCA-CMS version 3.0, MEDIS, Leiden, The Netherlands). Lesions were characterized according to the modified American College of Cardiology/American Heart Association (ACC/AHA) classification. 9 
Jeopardy score
The degree of multivessel coronary artery disease was defined by applying a jeopardy score (ie, a measure of potentially ischemic myocardium) according to Califf et al. 10 In this scoring system, the coronary tree is divided into 6 segments of nearly equal myocardial perfusion (eg, left anterior descending artery, major diagonal branch, circumflex coronary artery, major obtuse marginal branch, right coronary artery, and posterior descending artery). By applying a point score of 2 for each significant lesion and an additional 2 points for each vessel distal to that lesion, a total maximal score of 12 can be achieved.
Statistical analysis
Differences between groups were assessed by the 2 analysis for categorical variables and the unpaired Student t test or Mann-Whitney test for continuous variables when appropriate. Receiver operating characteristic curve analysis was performed to establish the value of the jeopardy score most predictive for catheterization laboratory events and acute MACCEs. Predictors of occurrence of catheterization laboratory events and MACCEs were evaluated with multivariable logistic regression analysis. Only variables with a value of P Յ .10 in the univariate analysis or considered relevant based on the literature and the experience of the senior operators were selected and included into the regression model. Probability values Ͻ.05 were considered significant. Data were analyzed with SPSS 10.0.5 (SPSS Inc, Chicago, Ill).
Results
Patient population
Patients in group A were older than in group B (Table I). The majority of patients (approximately 90%) in both groups had multivessel disease, and almost 30% of them had unstable angina at the time of the procedure. Left ventricular EF was 26% Ϯ 4% in group A and 27% Ϯ 4% in group B (P ϭ .20). Mean blood pressure at the beginning of the procedure was lower in group A than in group B (89 Ϯ 16 mm Hg vs 98 Ϯ 15 mm Hg, respectively, P ϭ .004). However, the rate of systolic blood pressure Ͻ100 mm Hg was similar in the 2 groups (18% in group A and 11% in group B, P ϭ .23). In no case was systolic blood pressure Ͻ90 mm Hg at the beginning of the procedure. The presence of PVD was similar in the 2 groups (group A, 16.5% vs group B, 12.5%, P ϭ .52).
Angiographic and procedural characteristics
Vessels treated were larger in group A than in group B (Table II) . Lesions were more often complex in group A. In each patient, no more than one vessel was treated. The number of treated lesions was 2.0 Ϯ 1.0 in group A and 1.7 Ϯ 0.8 in group B (P ϭ .21). The jeopardy score was higher in group A than in group B (8.0 Ϯ 2.8 vs 6.7 Ϯ 2.4, P ϭ .008) (Figure 1 ). Angioplasty to the sole remaining vessel was performed in 3 patients in group A (2.3%) and in none in group B (P ϭ .057). Angiographic success was similar in the 2 groups (94% vs 95%, P ϭ .72). Stent implantation was performed in 72% of patients in group A and 60% in group B (P ϭ .13); direct stenting was performed in 35% of cases in group A and 32% in group B (P ϭ .55). Rotational atherectomy was performed in 7 of 61 (11.5%) cases in group A and in 2 of 72 (2.8%) in group B (P ϭ .049). Directional atherectomy was performed in 2 of 61 (3%) patients in group A and in 2 of 72 in group B (P ϭ .87). Glycoprotein IIb/IIIa inhibitors were electively used in 13% in group A and 17% in group B (P ϭ .57). (Tables III and IV) . However, slow flow was well tolerated only in patients with elective IABP support, in whom no hemodynamic consequences occurred.
Although patients in group A had more unfavorable angiographic characteristics and a higher jeopardy score, no patient in group A had inlaboratory events. In fact, although systolic pressure decreased to Ͻ85 mm Hg in 7 patients in group A (11.5%), diastolic pressure, augmented by an electively placed IABP, was maintained at Ͼ90 mm Hg at all times. In contrast, severe hemodynamic instability (nonresponsive to conventional pharmacological approach) occurred in 11 patients in group B (15%, P ϭ .001 vs group A), and all of them received urgent IABP support. Three had slow flow after balloon dilation of a lesion in a saphenous vein graft. The other 8 patients had this complication because of dissection after balloon dilation of a Table III . The mean jeopardy score in the patients crossed over to IABP was 8.4 Ϯ 2.5 (range 6-12). By receiver operating curve, we identified a jeopardy score Ͼ6 as the better cutoff value to predict the oc- VF, Ventricular fibrillation; VT, ventricular tachicardia; CPA, cardiopulmonary arrest; AMI, acute myocardial infarction, both Q wave and non-Q wave; CABG, coronary artery bypass graft. *Groin hematoma.
currence of intraprocedural events (sensitivity 100%, specificity 80%). Intraprocedural events rate was similar in the 2 groups with jeopardy score Յ6 (0%, group A vs 13%, group B, P ϭ .13), whereas it was higher in group B when the jeopardy score was Ͼ6 (0%, group A vs 21%, group B, P ϭ .010).
The following variables were entered into a multivariable model for predicting acute MACCEs: sex, history of hypertension, mean blood pressure, stent implantation, elective IABP, reference vessel diameter, lesions length, minimal lumen diameter, and jeopardy score. By stepwise logistic regression analysis, elective IABP support (OR 0.11 [95% CI 0.21-0.60], P ϭ .011), jeopardy score (OR 5.37 [95% CI 1.10-8.70], P ϭ .040), and female sex (OR 2.72 [95% CI 1.85-3.10], P ϭ .015) were the correlates of intraprocedural events.
Inhospital MACCEs
Weaning off balloon pump support occurred in 3.9 Ϯ 5.8 hours (range 0.7-24) in group A and in 12.0 Ϯ 17.7 hours (range 8-72) in group B (P ϭ .005). Inhospital MACCEs were similar in the 2 groups but numerically more frequent in group B (Table IV) . Death occurred in one patient in group A (who had percutaneous transluminal coronary angioplasty in the single remaining circulation) and 3 in group B (who had severe hemodynamic instability and urgent IABP counterpulsation) (P ϭ .23). No patient had urgent bypass operation in the 2 groups. No patient in group A had vascular complications, whereas 2 patients with urgent IABP insertion had groin hematoma (P ϭ .25). No patients in the 2 groups needed a blood transfusion or had limb ischemia. Length of hospital stay was 2.9 Ϯ 1.7 days (range 2-9) in group A and 3.0 Ϯ 1.4 days (range 2-8) in group B (P ϭ .83). Considering only patients who had IABP support in both groups, length of hospital stay was 2.9 Ϯ 1.7 days (range 2-9) in group A and 5.0 Ϯ 2.1 days (range 2-9) in group B (P ϭ .003).
Discussion
The main result of the current study is that prophylactic use of IABP support among high-risk patients (in particular females with poor left ventricular systolic function and high jeopardy score) undergoing PCI contributes to an uncomplicated and successful outcome. In fact, although clinical and angiographic characteristics were less favorable, the early outcome of patients with elective IABP was better than patients with provisional hemodynamic support.
Rationale for elective IABP support in patients with poor left ventricular ejection fraction IABP counterpulsation helps to maintain cardiac output by reduction of the afterload (with consequent reduction of oxygen consumption and myocardial ischemia) and may augment coronary perfusion.
11,12 IABP use as an adjunct to PCI has been described where angioplasty is complicated by abrupt or late vessel closure 2 or before surgery after unsuccessful angioplasty. IABP is also used during PCI of an unprotected left main coronary stenosis or a protected left main stenosis associated with moderately depressed left ventricular function, in high-risk rotational atherectomy, 7 and during PCI in the setting of acute anterior infarction with high left ventricular filling pressure or extensive regional wall motion abnormalities. [13] [14] [15] The patient with severe depression in left ventricular systolic function represents a challenge for the interventionalist. The hemodynamic consequences of reducing coronary flow during balloon inflation or acute coronary occlusion are greater in these subsets of patients and have promoted consideration of means of supporting the circulation during coronary angioplasty procedures. 3 Even the availability of stents and the possibility of performing direct stenting may not eliminate the problem that stent deliverability may not always be possible and occasional flow-limiting dissections can develop proximal or distal to a stent. According to the results of the current study, because of concern about the amount of myocardium supplied by the target vessel, an elective IABP should be considered before starting a procedure in patients with EF Յ30% and jeopardy score Ͼ6, which is lower than the jeopardy score of 8 that we used to stratify patients for this study. The jeopardy score is a simple method of estimating the risk of inhospital complications during PCI. 10 It has been demonstrated that in addition to the number of diseased vessels, the location of the obstructions and the status of the left ventricle affect the prognosis of patients with coronary artery disease. 9, 18, 19 This approach should be considered when the interventionalist is asked to treat an artery that provides blood to the remaining viable myocardium. No patient who received an elective IABP had diastolic pressure lower than 90 mm Hg, thus maintaining coronary perfusion. In contrast, hemodynamic instability occurred in 17% of patients in group B, and in 92% of these patients, urgent IABP support was necessary.
A very important aspect to consider is cost containment in health care today. We observed that the average hospital stay was 2.4 days shorter for patients with elective IABP placement (group A) than for those with provisional IABP support (group B). Also, the IABP support duration was longer in the provisional than in the elective approach.
Vascular complications
Peripheral vascular complications and bleeding related to IABP have remained a major concern in studies evaluating supported percutaneous revascularization. [14] [15] [16] 20 In fact, IABP counterpulsation was previously associated with a high incidence of vascular complications (9%-43%). In the recently published results from the Benchmark Counterpulsation Outcomes Registry, 1 the incidence of both major limb ischemia (0.9%) and major bleeding (0.8%) was lower than in the previously reported experiences. Accordingly, in our study, the incidence of vascular complication was very low. This may be explained by the availability of the 8F catheter, which makes this strategy safer, reducing the occurrence of vascular complications. 1 
Study limitations
Although these data are provocative and encouraging, several limitations must be acknowledged. Indeed, this is a retrospective, nonrandomized study, with a relatively small sample size. Myocardial viability was not systematically assessed. Therefore, the current study is lacking in evaluation of the correlation between the degree of myocardial viability and the development of hemodynamic compromise during PCI. This study started when direct stenting was not so widely applied. It may be possible that more frequent use of direct stenting could narrow the differences between the 2 groups. In most cases, CK-MB concentration was assessed only when the total CK concentration was above the normal value.
